ginsenoside rh2 has been researched along with Chromosome-Defective Micronuclei in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Liu, K; Wang, Z; Zheng, Q; Zheng, R | 1 |
1 other study(ies) available for ginsenoside rh2 and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cyclophosphamide; DNA Damage; Drugs, Chinese Herbal; Female; Ginsenosides; Immunosuppressive Agents; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micronuclei, Chromosome-Defective; Panax; Tumor Burden; Xenograft Model Antitumor Assays | 2006 |